Feasibility of an Asthma Online Social Intervention
Launched by QUEEN MARY UNIVERSITY OF LONDON · Apr 12, 2023
Trial Information
Current as of June 22, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is exploring a new online support program for people with troublesome asthma. The study aims to see if this program is easy to use and helpful for patients. Participants will meet with their primary care doctor, who will introduce them to a safe online community where they can connect with other asthma patients. The researchers want to find out if patients like this online support and if they can successfully gather information about its effects on asthma management.
To take part in this study, you need to be at least 16 years old, have a diagnosis of asthma, and experience difficulties controlling your symptoms. You should also be comfortable using English to communicate during the consultations. The study is currently looking for participants, and it's important to note that people who are in palliative care or live in long-term care facilities cannot join. If you decide to participate, you can expect to engage in a consultation with your doctor and share your experiences to help improve asthma care for others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Eligibility criteria for receiving the intervention in the feasibility study:
- • Patients with a diagnosis of asthma indicated in online clinical records.
- • Aged 16 years and above.
- • Have expressed, in the questionnaire survey, interest in receiving a digital social intervention.
- • Experience troublesome asthma (i.e. asthma control test (ACT) score of less than 20).
- • Sufficiently fluent in English to take part in a consultation and subsequent data collection procedures.
- • Competent to consent for themselves, as determined by a qualified primary care healthcare professional.
- Exclusion Criteria:
- • Patients who are
- • Palliative or end-of-life.
- • Receiving institutional long-term care (i.e. receiving total care in residential homes or living in nursing homes).
- • Already a member of the ALUK OHC or other asthma OHCs/Facebook groups (general use of social media will not prevent participation).
About Queen Mary University Of London
Queen Mary University of London is a prestigious research-intensive institution recognized for its commitment to advancing medical science and improving health outcomes. As a leading sponsor of clinical trials, the university harnesses its academic excellence and innovative research capabilities to explore groundbreaking treatments and therapies across various medical disciplines. With a focus on collaboration, the institution engages with a diverse network of clinicians, researchers, and industry partners to ensure rigorous study design, ethical conduct, and the translation of research findings into clinical practice. Queen Mary University of London is dedicated to contributing to the global body of knowledge in healthcare through high-quality clinical research that prioritizes patient safety and welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Anna De Simoni, PhD
Principal Investigator
Clinical Reader in Primary Care Research, Queen Mary University of London
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported